Scailyte

Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. Scailyte has developed AI technology to discover complex disease patterns from single-cell data. Scailyte's AI-based software, ScaiVision, provides best-in-class performance for supervised pattern recognition analysis of single-cell data. ScaiVision enables customers to reduce data analysis time and cost while increasing groundbreaking insights. Additionally, Scailyte utilizes its expertise in single-cell technology and AI-based data analysis solutions to offer biomarker discovery services. During the drug discovery and development process, Scailyte supports pharmaceutical companies by introducing and implementing single-cell approaches to uncover novel disease mechanisms and identify biomarkers for drug efficacy, toxicity, and patient stratification.